Filter results

Pharmaceutical Industry Reports

By Geography
By Sector
By Publication Type
Benefit from discounts when you add multiple products to your basket
2 Products SAVE 10%
3 Products SAVE 15%
4 Products SAVE 20%
5 Products SAVE 25%
6 Products SAVE 30%
7 - 20 Products SAVE 35%
21 Products or more SAVE 40%
Showing
1-20 of 98
Algeria Pharmaceuticals & Healthcare Report

Algeria Pharmaceuticals & Healthcare Report

Pub date:10 Aug 2015

BMI View: Algeria's growing domestic pharmaceutical sector and restrictions on imports will result in the country importing a smaller proportion of its medicines over the long term. Foreign drugmakers that engage in local manufacturing ...
$1,295.00
Read More
Angola Pharmaceuticals & Healthcare Report

Angola Pharmaceuticals & Healthcare Report

Pub date:05 Aug 2015

BMI View: Growth in Angola's healthcare sector will remain subdued over the near term as lower oil prices persist. A consequence of the oil price crash has seen a sizeable cut in the much-needed ...
$1,295.00
Read More
Argentina Pharmaceuticals & Healthcare Report

Argentina Pharmaceuticals & Healthcare Report

Pub date:07 Aug 2015

BMI View: The improvement in Arg entina's business environment that is expected take place with the next government administration will contribute to increased market attractiveness to pharmaceuticals and healthcare investors. Moreover, a recent agreement ...
$1,295.00
Read More
Australia Pharmaceuticals & Healthcare Report

Australia Pharmaceuticals & Healthcare Report

Pub date:27 Jul 2015

BMI View: The Australian pharmaceutical market is expected to continue on a moderate growth trajectory over our forecast period. This is mainly explained by rising chronic disease burden as well as government funding to list ...
$1,295.00
Read More
Austria Pharmaceuticals & Healthcare Report

Austria Pharmaceuticals & Healthcare Report

Pub date:13 Aug 2015

BMI View: While we view the Austrian pharmaceutical and healthcare market as relatively stable and insulated from sudden downgrades, we highlight that certain economic factors pose a risk to public spending in particular. The Austrian ...
$1,295.00
Read More
Bahrain Pharmaceuticals & Healthcare Report

Bahrain Pharmaceuticals & Healthcare Report

Pub date:24 Aug 2015

BMI View: Bahrain's government will continue in its attempts at containing the rapidly expanding cost of healthcare. Private sector engagement and increasing generic substitution will continue to be employed, although government spending on the ...
$1,295.00
Read More
Bangladesh Pharmaceuticals & Healthcare Report

Bangladesh Pharmaceuticals & Healthcare Report

Pub date:09 Jun 2015

BMI View: Bangladesh's pharmaceutical and healthcare sector growth will continue to stand on robust long-term fundamentals, including population growth, rising inc omes, urbanisation and economic expansion. Moreover, the country's efforts to increase drug ...
$1,295.00
Read More
Belarus Pharmaceuticals & Healthcare Report

Belarus Pharmaceuticals & Healthcare Report

Pub date:02 Jun 2015

BMI View: Collapsing external trade will have a highly damaging impact on living standards in Belarus, impacting incomes, employment and consumer sentiment, and we expect the pharmaceutical sector to be hurt by these factors. We ...
$1,295.00
Read More
Belgium Pharmaceuticals & Healthcare Report

Belgium Pharmaceuticals & Healthcare Report

Pub date:16 Jun 2015

BMI View: With structurally higher prices than many regional markets and quickly rising pharmaceutical consumption, Belgium will continue to present a high level of potential reward to drugmaker . Notably, a distinct lack of price transparency ...
$1,295.00
Read More
Botswana Pharmaceuticals & Healthcare Report

Botswana Pharmaceuticals & Healthcare Report

Pub date:28 Aug 2015

BMI View: Communicable diseases will continue to dominate Botswana's disease profile, with HIV/AIDS posing the greatest burden. The government's provision of free antiretroviral treatment will provide opportunities for generic drugmakers within the ...
$1,295.00
Read More
Brazil Pharmaceuticals & Healthcare Report

Brazil Pharmaceuticals & Healthcare Report

Pub date:26 Aug 2015

BMI View: Continued focus on foreign investment along with the expansion of telemedicine and governmental action to improve medical access will keep Brazil and appealing destination for drugmakers and healthcare companies in coming years, particularly ...
$1,295.00
Read More
Bulgaria Pharmaceuticals & Healthcare Report

Bulgaria Pharmaceuticals & Healthcare Report

Pub date:18 Aug 2015

BMI View: Strong pharmaceutical sales growth in 2015 will be moderated over the medium term by cost containment measures. Healthcare payers in Central and Eastern Europe will become increasingly assertive in using their purchasing power to ...
$1,295.00
Read More
Cambodia Pharmaceuticals & Healthcare Report

Cambodia Pharmaceuticals & Healthcare Report

Pub date:02 Jul 2015

BMI View: Despite improvements to the healthcare sector, high out of pocket expenditure means that access to healthcare will remain a challenging issue in Cambodia. Further investments in the sector will boost overall care quality ...
$1,295.00
Read More
Cameroon Pharmaceuticals & Healthcare Report

Cameroon Pharmaceuticals & Healthcare Report

Pub date:07 Aug 2015

BMI View : Cameroon's healthcare sector development and improved access to medicines will continue to benefit from global aid funds and growing private consumption. Also, the Cameroonian government sustained commitment to enhancing economic development through ...
$1,295.00
Read More
Canada Pharmaceuticals & Healthcare Report

Canada Pharmaceuticals & Healthcare Report

Pub date:18 Aug 2015

BMI View: T he second largest market in the Americas region, d rugmakers operating in Canada will continue to benefit from high per capita spending on pharmaceuticals and rising public sector procurement as a result ...
$1,295.00
Read More
Central America Pharmaceuticals & Healthcare Report

Central America Pharmaceuticals & Healthcare Report

Pub date:30 Jul 2015

BMI View: Growing demand for pharmaceuticals, compounded by underdeveloped manufacturing capabilities will ensure commercial opportunities for foreign investors within Central America over the long term. Multinational drugmakers and medical suppliers will also continue to benefit ...
$1,295.00
Read More
Chile Pharmaceuticals & Healthcare Report

Chile Pharmaceuticals & Healthcare Report

Pub date:02 Jul 2015

BMI View : Highlighted by the passing of the 'Ricarte Soto Law' , Chile will maintain its attractiveness as a growth market for drugmakers as the government displays a firm commitment to expanding public access to health ...
$1,295.00
Read More
China Pharmaceuticals and Healthcare Report

China Pharmaceuticals and Healthcare Report

Pub date:01 Jun 2015

BMI View: The policy changes affecting China's pharmaceutical market will not deter the growth trajectory of local drugmakers. While competition has heightened due to the new tendering system, the system will remain more favourable ...
$1,295.00
Read More
Colombia Pharmaceuticals & Healthcare Report

Colombia Pharmaceuticals & Healthcare Report

Pub date:04 Aug 2015

BMI View: A growing burden of chronic diseases, along with the Colombian government's push toward improving its national healthcare system will ensure the country's retained appeal to multinational drugmakers and healthcare suppliers. Despite ...
$1,295.00
Read More
Cote d'Ivoire Pharmaceuticals & Healthcare Report

Cote d'Ivoire Pharmaceuticals & Healthcare Report

Pub date:31 Jul 2015

BMI View: Pharmaceutical expenditure in Cote d'Ivoire will be driven by both strong private consumption growth, in addition to public spending, through the introduction of the universal health insurance scheme. Growth will be driven ...
$1,295.00
Read More
Showing
1-20 of 98